- Home
- GS vs ISRG Comparison
GS vs ISRG Comparison
Compare GS & ISRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GS
- ISRG
- Stock Information
- Founded
- GS 1869
- ISRG 1995
- Country
- GS United States
- ISRG United States
- Employees
- GS N/A
- ISRG N/A
- Industry
- GS Investment Bankers/Brokers/Service
- ISRG Medical/Dental Instruments
- Sector
- GS Finance
- ISRG Health Care
- Exchange
- GS Nasdaq
- ISRG Nasdaq
- Market Cap
- GS 187.7B
- ISRG 200.0B
- IPO Year
- GS 1999
- ISRG 2000
- Fundamental
- Price
- GS $637.32
- ISRG $510.09
- Analyst Decision
- GS Buy
- ISRG Buy
- Analyst Count
- GS 15
- ISRG 18
- Target Price
- GS $602.54
- ISRG $583.47
- AVG Volume (30 Days)
- GS 1.8M
- ISRG 1.6M
- Earning Date
- GS 07-16-2025
- ISRG 07-17-2025
- Dividend Yield
- GS 1.89%
- ISRG N/A
- EPS Growth
- GS 68.40
- ISRG 23.31
- EPS
- GS 42.98
- ISRG 6.83
- Revenue
- GS $53,044,000,000.00
- ISRG $8,714,900,000.00
- Revenue This Year
- GS $9.36
- ISRG $17.90
- Revenue Next Year
- GS $4.33
- ISRG $15.15
- P/E Ratio
- GS $14.78
- ISRG $74.59
- Revenue Growth
- GS 13.52
- ISRG 19.08
- 52 Week Low
- GS $437.37
- ISRG $413.82
- 52 Week High
- GS $672.19
- ISRG $616.00
- Technical
- Relative Strength Index (RSI)
- GS 67.79
- ISRG 38.11
- Support Level
- GS $609.59
- ISRG $506.54
- Resistance Level
- GS $632.27
- ISRG $523.53
- Average True Range (ATR)
- GS 10.70
- ISRG 11.00
- MACD
- GS 0.76
- ISRG -4.83
- Stochastic Oscillator
- GS 96.28
- ISRG 21.99
About GS Goldman Sachs Group Inc. (The)
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 14% of its revenue comes from investment banking, 42% from trading, 20% from asset & wealth management, 15% from net interest income, and 9% from other principal transactions. Around 64% of the company's net revenue is generated in the Americas, 13% in Asia, and 23% in Europe, the Middle East, and Africa.
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.